Omics-Nano-Crispr Approaches for Oncology

Omics-Nano-CRISPR represents an emerging framework integrating omics technologies, nanotechnology, and CRISPR-based gene editing to advance cancer diagnosis, treatment, and personalized medicine. Omics platforms, including genomics, provide insights into the molecular mechanisms of cancer, while nanotechnology enables targeted drug delivery and improved biomarker detection. Combined with the precision of CRISPR gene-editing tools, these approaches identify cancer-specific targets, enhance therapeutic methods, and minimize treatment-related side effects. As oncology moves toward precision medicine, the integration of omics, nanotechnology, and CRISPR may further improve cancer research. Omics-Nano-CRISPR Approaches for Oncology explores multiple omics, nanotechnology, and CRISPR-Cas9, which develop precision cancer medicine and personalized healthcare. It examines various combinatorial strategies for combating major cancers, future oncological research, and subsequent translational and clinical applications. This book covers topics such as algorithmic bias, precision medicine, and stem cells, and is a useful resource for medical and healthcare professionals, engineers, academicians, researchers, and scientists.